+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Amgen Inc. - logo

Amgen is an international biotechnology company based in California, USA. Amgen is committed to using their experience in human genetics and biologics manufacturing to create innovative treatments for life threatening diseases particularly in areas of unmet medical need where limited treatment options exist. Amgen manufactures a wide range of therapeutic products including Aranesp, Corlanor, Neulasta and Prolia.

Atopic Dermatitis - Competitive Landscape, 2026 - Product Thumbnail Image

Atopic Dermatitis - Competitive Landscape, 2026

  • Report
  • January 2026
  • 240 Pages
  • Global
From
From
Phenylbutazone API Market - Global Forecast to 2030 - Product Thumbnail Image

Phenylbutazone API Market - Global Forecast to 2030

  • Report
  • August 2025
  • 191 Pages
  • Global
From
From
From
Atherosclerosis Therapeutics Market 2024-2028 - Product Thumbnail Image

Atherosclerosis Therapeutics Market 2024-2028

  • Report
  • June 2024
  • 145 Pages
  • Global
From
Therapeutic Injectable Drugs - Devices, Products and Markets - Product Thumbnail Image

Therapeutic Injectable Drugs - Devices, Products and Markets

  • Report
  • June 2023
  • 235 Pages
  • Global
From
Osteoarthritis Therapeutics Market - Global Forecast 2026-2032 - Product Thumbnail Image

Osteoarthritis Therapeutics Market - Global Forecast 2026-2032

  • Report
  • January 2026
  • 182 Pages
  • Global
From
Rheumatology Therapeutics Market - Global Forecast 2026-2032 - Product Thumbnail Image

Rheumatology Therapeutics Market - Global Forecast 2026-2032

  • Report
  • January 2026
  • 193 Pages
  • Global
From
From
DTP Vaccines Market Report 2026 - Product Thumbnail Image

DTP Vaccines Market Report 2026

  • Report
  • February 2026
  • 250 Pages
  • Global
From
From
From
From
From
Loading Indicator